Grown Rogue International (GRUSF) Share-based Compensation (QoQ) (2012 - 2026)
Grown Rogue International (GRUSF) Share-based Compensation (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.81% |
| Mar 31, 2026 | 100.00% |
| Dec 31, 2025 | -200.00% |
| Sep 30, 2025 | 30,619,206,454.59% |
| Jun 30, 2025 | -99.55% |
| Mar 31, 2025 | 100.00% |
| Dec 31, 2024 | -175,455,960.56% |
| Sep 30, 2024 | 948.67% |
| Jun 30, 2024 | -63.32% |
| Oct 31, 2023 | 50.33% |
| Jul 31, 2023 | 102.21% |
| Apr 30, 2023 | 71.81% |
| Jan 31, 2022 | -80.54% |
| Oct 31, 2021 | 238.11% |
| Jul 31, 2021 | -139.55% |
| Apr 30, 2021 | -20.71% |
| Jan 31, 2021 | 335.69% |
| Oct 31, 2020 | -82.28% |
| Jul 31, 2020 | 35.57% |
| Apr 30, 2020 | 362.67% |